Table 1.
Category | All patients (N = 44) |
---|---|
Median age, years (range) | 65 (40–79) |
Male/female, n (%) | 24 (55)/20 (45) |
Race, n (%) | |
White | 39 (89) |
Black | 3 (7) |
Other | 2 (5) |
Mean BSA, m2 (SD) | 1.97 (0.24) |
Ixazomib dose range,* mg | 0.8–8.9 |
Ixazomib dose level, n (%) | |
0.48 mg/m2 | 1 (2) |
0.80 mg/m2 | 3 (7) |
1.20 mg/m2 | 2 (5) |
1.68 mg/m2 | 4 (9) |
2.23 mg/m2 | 3 (7) |
2.97 mg/m2 | 26 (59) |
3.95 mg/m2 | 5 (11) |
*Actual administered dose
BSA body surface area, SD standard deviation